Treatment of Schizophrenia Through Internet-Based Psychoeducation

Schizophrenia Clinical Trial

Official title:

Schizophrenia Patient and Family Continuity of Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00051233
• Other study ID #: R01MH063484
• Secondary ID: R01MH063484DSIR
• Status: Completed
• Phase: Phase 2
• First received: January 7, 2003
• Last updated: June 26, 2014
• Start date: January 2003
• Est. completion date: January 2005

Study information

• Verified date: June 2014
• Source: University of Pittsburgh
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to assess the effectiveness of a Web-based psychoeducational program in helping people with schizophrenia and their families manage the disease.

Description:

This study will provide a comprehensive psychoeducational program which includes education, social support, information, coping strategies, and guidance from mental health, social services, and medical professionals. This study will work to reduce relapse, facilitate patient rehabilitation, decrease family distress, and improve family well being.

Patients and their families participate in an in-person Psychoeducational Survival Skills Workshop that is designed to provide patients and their families with basic information about schizophrenia and its treatment. After the workshop, participants are provided with 6 Web-based modules that are designed to increase mental health and schizophrenia knowledge. Patient relapse, family distress, family knowledge of schizophrenia, and data on user's acceptance and utilization are measured to determine the intervention's effectiveness.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: January 2005
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 14 Years to 55 Years

Eligibility

Inclusion Criteria

• DSM-IV diagnosis of schizophrenia or schizoaffective disorder

• At least 4 hours/week in-person contact with a family member

• Primary caregiver with a telephone

• Patient and primary caregiver speak and read English

Exclusion Criteria:

• Enrolled in another clinical trial

• Evidence of organic brain syndrome

• Current alcohol or substance abuse that could explain the presenting index psychotic episode

• DSM-IV diagnosis of psychoactive substance dependency

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Psychotic Disorders
• Schizoaffective Disorder
• Schizophrenia

Intervention

Procedure:
• World Wide Web-Based Psychoeducation

Locations

Country	Name	City	State
United States	University of Pittsburgh Western Psychiatric Institute and Clinic	Pittsburgh	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
University of Pittsburgh	National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States,